Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclacel Pharmaceuticals

0.3700
-0.2350-38.84%
Post-market: 0.42000.0500+13.51%19:59 EDT
Volume:7.67M
Turnover:3.67M
Market Cap:8.79M
PE:-0.01
High:0.6600
Open:0.6051
Low:0.3528
Close:0.6050
Loading ...

Cyclacel Pharmaceuticals Inc. Declares Quarterly Cash Dividend of $0.15 Per Share on Preferred Stock

Reuters
·
04 Jun

Cyclacel Pharmaceuticals Regains Nasdaq Compliance After Meeting Minimum Bid Price Requirement

Reuters
·
04 Jun

Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
04 Jun

Cyclacel Pharmaceuticals Approves Reverse Stock Split Amendment

Reuters
·
24 May

Cyclacel Pharmaceuticals Reports First Quarter Results: General and Administrative Expenses Rise by $2.6 Million, Plogosertib Focused Development Continues

Reuters
·
16 May

Cyclacel Pharmaceuticals Inc. Files Initial Beneficial Ownership Statement; Ho Kee Wee Named as 10% Owner

Reuters
·
16 May

Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update

THOMSON REUTERS
·
15 May

Cyclacel Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership, Naming Tan Kok Hui as 10% Owner

Reuters
·
15 May

Cyclacel Pharmaceuticals Approves Reverse Stock Split Amendment

Reuters
·
14 May

BRIEF-Cyclacel Pharmaceuticals Announces Stock Split

Reuters
·
07 May

Cyclacel Pharmaceuticals Announces Stock Split

THOMSON REUTERS
·
07 May

Cyclacel Pharmaceuticals Inc - Announces 1-for-16 Reverse Stock Split Effective May 12

THOMSON REUTERS
·
07 May

Fitters Diversified Entered Exchange Agreement With Cyclacel Pharmaceuticals, Inc

Reuters
·
06 May

Cyclacel Pharmaceuticals : Entered Into an Exchange Agreement With Fitters Diversified Berhad

THOMSON REUTERS
·
06 May

Cyclacel : Under Agreement, All of Ordinary Shares of Fitters' Subsidiary, Fitters Sdn. Bhd., Shall Be Exchanged for Common Stock, of Co

THOMSON REUTERS
·
06 May

BRIEF-Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results And Provides Business Update

Reuters
·
03 Apr

Cyclacel Pharmaceuticals Reports Q4 EPS Of $(0.33)

Benzinga
·
03 Apr

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

THOMSON REUTERS
·
03 Apr

Press Release: Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

Dow Jones
·
03 Apr

Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock

THOMSON REUTERS
·
24 Mar